Treatment of pruritus due to chronic obstructive liver disease.
D001559:Benzhydryl Compounds / Q000627:therapeutic use; D002744:Chlorpheniramine / Q000627:therapeutic use; D002761:Cholangitis / Q000150:complications; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000150:complications*; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology; D011897:Random Allocation; D016593:Terfenadine
D001559:Benzhydryl Compounds; D006634:Histamine H1 Antagonists; D002792:Cholestyramine Resin; D002744:Chlorpheniramine; D016593:Terfenadine